Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

ClinicalTrials.gov ID: NCT01363011

Public ClinicalTrials.gov record NCT01363011. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 12:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is to characterize the effect of cobicistat-based regimens on parameters of renal function in participants with HIV infection and who have mild to moderate renal impairment, and to assess the safety and tolerability of the regimens in order to generate appropriate dosing recommendations.

Study identification

NCT ID
NCT01363011
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
106 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2011 (Type not available)
Primary completion
Jan 2013 (Actual)
Completion
Feb 2015 (Actual)
Last update posted
May 2, 2016

2011 – 2015

United States locations

U.S. sites
34
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Spectrum Medical Group Phoenix Arizona 85012 —
Health for Life Clinic Little Rock Arkansas 72207 —
AHF Research Center Beverly Hills California 90211 —
Kaiser Permanente Los Angeles California 90027 —
Peter J. Ruane, M.D., Inc. Los Angeles California 90036 —
Anthony Mills, MD, Inc. Los Angeles California 90069 —
Orange Coast Medical Group Newport Beach California 92663 —
East Bay AIDS Center Oakland California 94609 —
University of California, Davis Sacramento California 01105 —
Metropolis Medical San Francisco California 94115 —
National Jewish Health Denver Colorado 80206 —
Yale University School of Medicine AIDS Program New Haven Connecticut 06520 —
Whitman Walker Clinic Washington D.C. District of Columbia 20009 —
Medical Faculty Associates Washington D.C. District of Columbia 20037 —
Therafirst Medical Center Fort Lauderdale Florida 33308 —
Broward Health Fort Lauderdale Florida 33311 —
Gary J. Richmond.M.D.,P.A. Fort Lauderdale Florida 33316 —
Midway Immunology and Research Center Ft. Pierce Florida 34982 —
Orlando Immunology Center Orlando Florida 32803 —
IDOCF/ValueHealthMD, LLC Orlando Florida 32806 —
Infectious Disease Specialists of Atlanta Decatur Georgia 30033 —
Mercer University/ Mercer Medicine Clinical Research Macon Georgia 31201 —
Northstar Medical Center Chicago Illinois 60657 —
The Research Institute Springfield Massachusetts 01105 —
Central West Clinical Research, Inc. St Louis Missouri 63108 —
ID Care Hillsborough New Jersey 08844 —
North Shore University Hospital Manhasset New York 11030 —
Chelsea Village Medical New York New York 10011 —
Mount Sinai Downtown Comprehensive Health Program New York New York 10011 —
AIDS Care Rochester New York 14607 —
Carolinas Medical Center Charlotte North Carolina 28207 —
Southwest Infectious Disease Clinical Research, Inc. Addison Texas 75001 —
Tarrant County Infectious Disease Associates Fort Worth Texas 76104 —
Therapeutic Concepts, PA Houston Texas 77004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01363011, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2016 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01363011 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →